Cargando…
Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic
During COVID-19 outbreak, a large number of children with severe inflammatory disease has been reported. This condition, named Pediatric Multi-inflammatory Syndrome temporally associated with COVID-19 (PIMS-TS) or Multisystem Inflammatory Syndrome associated with Coronavirus Disease 2019 (MIS-C), sh...
Autores principales: | Della Paolera, Sara, Valencic, Erica, Piscianz, Elisa, Moressa, Valentina, Tommasini, Alberto, Sagredini, Raffaella, Kiren, Valentina, Comar, Manola, Taddio, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940350/ https://www.ncbi.nlm.nih.gov/pubmed/33708752 http://dx.doi.org/10.3389/fped.2020.624248 |
Ejemplares similares
-
Clinical and Cytometric Study of Immune Involvement in a Heterogeneous Cohort of Subjects With RASopathies and mTORopathies
por: Valencic, Erica, et al.
Publicado: (2021) -
Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
por: Çaǧlayan, Şengül, et al.
Publicado: (2022) -
Biological and Clinical Changes in a Pediatric Series Treated with Off-Label JAK Inhibitors
por: Pin, Alessia, et al.
Publicado: (2020) -
Ultrasonographic Assessment for Tenosynovitis in Juvenile Idiopathic Arthritis with Ankle Involvement: Diagnostic and Therapeutic Significance
por: Della Paolera, Sara, et al.
Publicado: (2022) -
Efficacy of anakinra on rebound of multisystem inflammatory syndrome
por: Brisca, Giacomo, et al.
Publicado: (2022)